Literature DB >> 28667676

Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity.

Noa Shoshan1, Amir Segev1, Hila Abush1, Tomer Mizrachi Zer-Aviv1, Irit Akirav1.   

Abstract

Exposure to excessive or uncontrolled stress is a major factor associated with various diseases including posttraumatic stress disorder (PTSD). The consequences of exposure to trauma are affected not only by aspects of the event itself, but also by the frequency and severity of trauma reminders. It was suggested that in PTSD, hippocampal-dependent memory is compromised while amygdala-dependent memory is strengthened. Several lines of evidence support the role of the endocannabinoid (eCB) system as a modulator of the stress response. In this study we aimed to examine cannabinoids modulation of the long-term effects (i.e., 1 month) of exposure to a traumatic event on memory and plasticity in the hippocampus and amygdala. Following exposure to the shock and reminders model of PTSD in an inhibitory avoidance light-dark apparatus rats demonstrated: (i) enhanced fear retrieval and impaired inhibitory extinction (Ext), (ii) no long-term potentiation (LTP) in the CA1, (iii) impaired hippocampal-dependent short-term memory in the object location task, (iv) enhanced LTP in the amygdala, and (v) enhanced amygdala-dependent conditioned taste aversion memory. The cannabinoid CB1/2 receptor agonist WIN55-212,2 (0.5mg/kg, i.p.) and the fatty acid amide hydrolase (FAAH) inhibitor URB597 (0.3mg/kg, i.p.), administered 2 hr after shock exposure prevented these opposing effects on hippocampal- and amygdala-dependent processes. Moreover, the effects of WIN55-212,2 and URB597 on Ext and acoustic startle were prevented by co-administration of a low dose of the CB1 receptor antagonist AM251 (0.5mg/kg, i.p.), suggesting that the preventing effects of both drugs are mediated by CB1 receptors. Exposure to shock and reminders increased CB1 receptor levels in the CA1 and basolateral amygdala 1 month after shock exposure and this increase was also prevented by administering WIN55-212,2 or URB597. Taken together, these findings suggest the involvement of the eCB system, and specifically CB1 receptors, in the opposite effects of severe stress on memory and plasticity in the hippocampus and amygdala.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  CB1; LTP; URB597; extinction; posttraumatic stress disorder (PTSD); receptors

Mesh:

Substances:

Year:  2017        PMID: 28667676     DOI: 10.1002/hipo.22755

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  9 in total

1.  Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity.

Authors:  Amir Segev; Nachshon Korem; Tomer Mizrachi Zer-Aviv; Hila Abush; Rachel Lange; Garrett Sauber; Cecilia J Hillard; Irit Akirav
Journal:  Neuropsychopharmacology       Date:  2018-06-27       Impact factor: 7.853

2.  Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats.

Authors:  Maria Morena; Andrea Berardi; Paola Colucci; Maura Palmery; Viviana Trezza; Matthew N Hill; Patrizia Campolongo
Journal:  Neuropsychopharmacology       Date:  2017-12-21       Impact factor: 7.853

3.  Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.

Authors:  Akshayan Vimalanathan; Darryl C Gidyk; Mustansir Diwan; Flavia V Gouveia; Nir Lipsman; Peter Giacobbe; José N Nobrega; Clement Hamani
Journal:  Neuropharmacology       Date:  2020-01-13       Impact factor: 5.250

Review 4.  Cannabinoid Modulation of the Stressed Hippocampus.

Authors:  Franciele F Scarante; Carla Vila-Verde; Vinícius L Detoni; Nilson C Ferreira-Junior; Francisco S Guimarães; Alline C Campos
Journal:  Front Mol Neurosci       Date:  2017-12-19       Impact factor: 5.639

Review 5.  Do Adolescent Exposure to Cannabinoids and Early Adverse Experience Interact to Increase the Risk of Psychiatric Disorders: Evidence from Rodent Models.

Authors:  Anna Portugalov; Irit Akirav
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

6.  The infralimbic mineralocorticoid blockage prevents the stress-induced impairment of aversive memory extinction in rats.

Authors:  Kairo Alan Albernaz-Mariano; Carolina Demarchi Munhoz
Journal:  Transl Psychiatry       Date:  2022-08-24       Impact factor: 7.989

7.  Enhancing Endocannabinoid Signaling via β-Catenin in the Nucleus Accumbens Attenuates PTSD- and Depression-like Behavior of Male Rats.

Authors:  Tomer Mizrachi Zer-Aviv; Larglinda Islami; Peter J Hamilton; Eric M Parise; Eric J Nestler; Brenda Sbarski; Irit Akirav
Journal:  Biomedicines       Date:  2022-07-25

Review 8.  Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases-focusing on FAAH/MAGL inhibitors.

Authors:  Si-Yu Ren; Zhen-Zhen Wang; Yi Zhang; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2020-03-18       Impact factor: 6.150

Review 9.  The Endocannabinoid System as Modulator of Exercise Benefits in Mental Health.

Authors:  Sandra Amatriain-Fernández; Henning Budde; Thomas Gronwald; Carla Quiroga; Cristina Carreón; Gerardo Viana-Torre; Tetsuya Yamamoto; Claudio Imperatori; Sérgio Machado; Eric Murillo-Rodríguez
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.